BioCentury
ARTICLE | Clinical News

2B3-101 regulatory update

June 21, 2010 7:00 AM UTC

The COMP issued a positive opinion to grant Orphan Drug designation to to-BBB's 2B3-101 to treat glioma. The liposomal doxorubicin formulation, which is conjugated with glutathione to enhance delivery...